Geraniol — a Review of a Commercially Important Fragrance Material ⁎ W
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Retention Indices for Frequently Reported Compounds of Plant Essential Oils
Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5. -
Oxidation of Geraniol Using Niobia Modified With
Revista Facultad de Ingeniería, Universidad de Antioquia, No.91, pp. 106-112, Apr-Jun 2019 Oxidation of geraniol using niobia modified with hydrogen peroxide Oxidación de geraniol utilizando niobia modificada con peróxido de hidrógeno Jairo Cubillos 1*, Jose J. Martínez 1, Hugo Rojas 1, Norman Marín-Astorga2 1Grupo de Catálisis, Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia UPTC. Avenida Central del Norte 39-115. A.A. 150003 Tunja. Boyacá, Colombia. 2Eurecat U.S. Incorporated. 13100 Bay Park Rd. C.P. 77507. Pasadena, Texas, USA. ABSTRACT: Nb2O5 bulk and Nb2O5 modified with H2O2 were studied in the epoxidation of geraniol at 1 bar and room temperature. The structural and morphological properties ARTICLE INFO: for both catalysts were very similar, indicating that the peroxo-complex species were not Received: April 27, 2018 formed. The order of the reaction was one with respect to geraniol and close to zero respect Accepted: April 16, 2019 to H2O2, these values fit well with the kinetic data obtained. The geraniol epoxidation is favored by the presence of peroxo groups, which is reached using an excess of H2O2. Moreover, the availability of the geraniol to adopt the three-membered-ring transition state AVAILABLE ONLINE: was found as the best form for this type of compound. April 22, 2019 RESUMEN: El óxido de niobio (niobia), Nb2O5 y Nb2O5 modificado con H2O2 fue explorado como catalizador en la epoxidación de geraniol a 1 bar y temperatura ambiente. Las KEYWORDS: propiedades estructurales y morfológicas de ambos catalizadores fueron muy similares, Niobium oxide, peroxo lo cual sugiere que no se formaron especies de complejo peroxo. -
Searching for Novel Cancer Chemopreventive Plants and Their Products: the Genus Zanthoxylum
Current Drug Targets, 2011, 12, 1895-1902 1895 Searching for Novel Cancer Chemopreventive Plants and their Products: The Genus Zanthoxylum Francesco Epifano*,1, Massimo Curini2, Maria Carla Marcotullio2 and Salvatore Genovese1 1Dipartimento di Scienze del Farmaco, Università “G. D’Annunzio” di Chieti-Pescara, Via dei Vestini 31, 66013 Chieti Scalo (CH), Italy 2Dipartimento di Chimica e Tecnologia del Farmaco, Sezione di Chimica Organica, Università degli Studi di Perugia, Via del Liceo, 06123 Perugia, Italy Abstract: The genus Zanthoxylum (Rutaceae) comprises about 250 species, of which many are used as food, often as condiments, substituting pepper due to the pungent taste of fruits, seeds, leaves, and bark, and therapeutic remedies especially in Eastern Asian countries and in Central America. The whole plant is also consumed as an ingredient of soups and salads. The aim of this review is to examine in detail from a phytochemical and pharmacological point of view what is reported in the current literature about the anti-cancer and chemopreventive properties of phytopreparations or individual active compounds obtained from edible plants belonging to this genus. Keywords: Anti-cancer activity, cancer chemoprevention, edible plants, prenyloxyphenylpropanoids, Rutaceae, Zanthoxylum. INTRODUCTION EDIBLE PLANTS OF THE GENUS ZANTHOXYLUM EXHIBITING ANTI-CANCER PROPERTIES Cancer is nowadays one of the major causes of death all over the world. Although many therapeutic remedies have Zanthoxylum ailanthoides Siebold & Zucc. been developed and used, most of which with appreciable Zanthoxylum ailanthoides, commonly known as success, prevention and cure of this severe syndrome is a “Japanese prickly-ash”, is a plant originary of the East-Asia, research field of current interest. -
Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates S
Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2016/03/02/dmd.116.069633.DC1 1521-009X/44/5/771–780$25.00 http://dx.doi.org/10.1124/dmd.116.069633 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:771–780, May 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Catalytic Activities of Tumor-Specific Human Cytochrome P450 CYP2W1 Toward Endogenous Substrates s Yan Zhao, Debin Wan, Jun Yang, Bruce D. Hammock, and Paul R. Ortiz de Montellano Department of Pharmaceutical Chemistry, University of California, San Francisco (Y.Z., P.R.O.M.) and Department of Entomology and Cancer Center, University of California, Davis, CA (D.W., J.Y., B.D.H.) Received January 25, 2015; accepted February 29, 2016 ABSTRACT CYP2W1 is a recently discovered human cytochrome P450 enzyme 4-OH all-trans retinol, and it also oxidizes retinal. The enzyme much with a distinctive tumor-specific expression pattern. We show here less efficiently oxidizes 17b-estradiol to 2-hydroxy-(17b)-estradiol and that CYP2W1 exhibits tight binding affinities for retinoids, which have farnesol to a monohydroxylated product; arachidonic acid is, at best, Downloaded from low nanomolar binding constants, and much poorer binding constants a negligible substrate. These findings indicate that CYP2W1 probably in the micromolar range for four other ligands. CYP2W1 converts all- plays an important role in localized retinoid metabolism that may be trans retinoic acid (atRA) to 4-hydroxy atRA and all-trans retinol to intimately linked to its involvement in tumor development. -
Novel Intranasal Drug Delivery: Geraniol Charged Polymeric Mixed Micelles for Targeting Cerebral Insult As a Result of Ischaemia/Reperfusion
pharmaceutics Article Novel Intranasal Drug Delivery: Geraniol Charged Polymeric Mixed Micelles for Targeting Cerebral Insult as a Result of Ischaemia/Reperfusion Sara M. Soliman 1, Nermin M. Sheta 1, Bassant M. M. Ibrahim 2, Mohammad M. El-Shawwa 3 and Shady M. Abd El-Halim 1,* 1 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, 6th of October University, Central Axis, Sixth of October City, Giza 12585, Egypt; [email protected] (S.M.S.); [email protected] (N.M.S.) 2 Department of Pharmacology, Medical Research Division, National Research Centre, Dokki, Giza 12622, Egypt; [email protected] 3 Department of Physiology, Faculty of Medicine for Girls, Al-Azhar University, Cairo 11651, Egypt; [email protected] * Correspondence: [email protected]; Tel.: +20-11-199-94874 Received: 16 November 2019; Accepted: 13 January 2020; Published: 17 January 2020 Abstract: Brain damage caused by cerebral ischaemia/reperfusion (I/R) can lead to handicapping. So, the present study aims to evaluate the prophylactic and therapeutic effects of geraniol in the form of intranasal polymeric mixed micelle (PMM) on the central nervous system in cerebral ischaemia/reperfusion (I/R) injury. A 32 factorial design was used to prepare and optimize geraniol PMM to investigate polymer and stabilizer different concentrations on particle size (PS) and percent entrapment efficiency (%EE). F3 possessing the highest desirability value (0.96), with a PS value of 32.46 0.64 nm, EE of 97.85 1.90%, and release efficiency of 59.66 0.64%, was selected for ± ± ± further pharmacological and histopathological studies. In the prophylactic study, animals were classified into a sham-operated group, a positive control group for which I/R was done without treatment, and treated groups that received vehicle (plain micelles), geraniol oil, and geraniol micelles intranasally before and after I/R. -
Lemongrass Essential Oil Components with Antimicrobial and Anticancer Activities
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 21 June 2021 doi:10.20944/preprints202106.0500.v1 Review Lemongrass essential oil components with antimicrobial and anticancer activities Mohammad Mukarram 1,2,*, Sadaf Choudhary 1 , Mo Ahamad Khan 3 , Palmiro Poltronieri 4,* , M. Masroor A. Khan 1 , Jamin Ali 5 , Daniel Kurjak 2 and Mohd Shahid 6 1 Advance Plant Physiology Section, Department of Botany, Aligarh Muslim University, Aligarh 202002, India; [email protected] (M.M.); [email protected] (S.C.); [email protected] (M.M.A.K.) 2 Department of Integrated Forest and Landscape Protection, Faculty of Forestry, Technical University in Zvolen, T. G. Masaryka 24, 96001, Zvolen, Slovakia; [email protected] (D.K.) 3 Department of Microbiology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh 202002, India; [email protected] (M.A.K.) 4 Institute of Sciences of Food Productions, ISPA-CNR, National Research Council of Italy, via Monteroni km 7, 73100 Lecce, Italy; [email protected] (P.P.) 5 Centre for Applied Entomology & Parasitology, School of Life Sciences, Keele University, United Kingdom; [email protected] (J.A.) 6 Department of Microbiology, Immunology & Infectious Diseases, College of Medicine & Medical Sciences, Arabian Gulf University, Kingdom of Bahrain; [email protected] (M.S.) * Correspondence: [email protected] (P.P.); [email protected] (M.M.) Abstract: The prominent cultivation of lemongrass relies on the pharmacological incentives of its essential oil. The lemongrass essential oil (LEO) has a significant amount of citral (mixture of geranial and neral), isoneral, isogeranial, geraniol, geranyl acetate, citronellal, citronellol, germacrene-D, and elemol in addition to numerous other bioactive compounds. -
Combination of the Natural Product Capsaicin and Docetaxel
Sánchez et al. Cancer Cell Int (2019) 19:54 https://doi.org/10.1186/s12935-019-0769-2 Cancer Cell International PRIMARY RESEARCH Open Access Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase Belén G. Sánchez1, Alicia Bort1, Pedro A. Mateos‑Gómez1, Nieves Rodríguez‑Henche1 and Inés Díaz‑Laviada1,2* Abstract Background: Current chemotherapy for castration‑resistant prostate cancer is established on taxane‑based com‑ pounds like docetaxel. However, eventually, the development of toxic side efects and resistance limits the thera‑ peutic beneft being the major concern in the treatment of prostate cancer. Combination therapies in many cases, enhance drug efcacy and delay the appearance of undesired efects, representing an important option for the treat‑ ment of castration‑resistant prostate cancer. In this study, we tested the efcacy of the combination of docetaxel and capsaicin, the pungent ingredient of hot chili peppers, on prostate cancer cells proliferation. Methods: Prostate cancer LNCaP and PC3 cell lines were used in this study. Levels of total and phosphorylated forms of Akt, mTOR, S6, LKB1, AMPK and ACC were determined by Western blot. AMPK, LKB1 and Akt knock down was performed by siRNA. PTEN was overexpressed by transient transfection with plasmids. Xenograft prostate tumors were induced in nude mice and treatments (docetaxel and capsaicin) were administered intraperitoneally. Statistical analyses were performed with GraphPad software. Combination index was calculated with Compusyn software. Results: Docetaxel and capsaicin synergistically inhibited the growth of LNCaP and PC3 cells, with a combina‑ tion index lower than 1 for most of the combinations tested. -
Development of a Process for the Preparation of Linalool from Cis -2-Pinanol
1 DEVELOPMENT OF A PROCESS FOR THE PREPARATION OF LINALOOL FROM CIS -2-PINANOL Subash Ramnarain Buddoo Thesis submitted in fulfilment of the requirements for the degree DOCTOR TECHNOLOGIAE In the faculty of Applied Science at the NELSON MANDELA METROPOLITAN UNIVERSITY June 2008 Promoter : Prof. B. Zeelie Co-promoter : Dr. J. Dudas 2 ACKNOWLEDGEMENTS The author wishes to express his sincere appreciation to: • My promoters, Prof. B. Zeelie and Dr. J. Dudas for their assistance, guidance and encouragement to conclude this project; • The Department of Science and Technology for funding the project under the Support Programme for Industrial Innovation (SPII); • The THRIP fund for providing funds for the purchase of equipment required for the laboratory experimental investigations; • Teubes Pty. Ltd. for financial support, provision of starting material (CST and α-pinene) and for permission to use this material for a thesis; • S. Farnworth for the management of the CST project; • N. Siyakatshana for his assistance with the reaction kinetics and computer modelling of the process; • B. Cowan for assistance with the GC-MS analysis; and • My wife (Shelina), son (Kavish) and daughter (Sarisha) for their encouragement, patience and tolerance. 3 SUMMARY Linalool is a key intermediate for the production of important fragrance chemicals such as geraniol, nerol, geranial, and neral. Linalool can be produced via a two-step process from α-pinene which is a major component of crude sulphated turpentine (CST) a foul-smelling, volatile waste product of the pulp and paper industry. The key step in this process is the pyrolysis step which involves the isomerisation of cis -2- pinanol to linalool and requires high temperatures (600-650°C) and is not very selective due to the decomposition of the product itself under these conditions. -
Citronellol Cas No
SUMMARY OF DATA FOR CHEMICAL SELECTION -CITRONELLOL CAS NO. 106-22-9 BASIS OF NOMINATION TO THE CSWG The nomination of citronellol to the CSWG is based on high production volume, widespread human exposure, and an unknown potential for adverse health effects from long-term administration. Citronellol came to the attention of the CSPG because of information supplied by the Food and Drug Administration (FDA) from a review of “GRAS” substances used as spices and food additives. According to the FDA data, citronellol is found in 17 different spices. It is also a common flavoring in beverages and foods and is one of the most widely used fragrance materials, having the sweet aroma of rose. Occupational exposure to citronellol in the United States is significant, estimated to be over 160,000 workers in 62 industries. Citronellol is present in high concentrations in citronella, geranium, and rose oils, accounting for additional human exposure. It is also closely related to citronellal and seven esters also having “GRAS” status. SELECTION STATUS ACTION BY CSWG : 7/16/97 Studies requested : - Metabolism studies - Mechanistic studies to include examination of the role of α 2u -globulin in transport - Carcinogenicity - In vitro cytogenetic analysis - In vivo micronucleus assay Priority : Moderate Rationale/Remarks : - High production levels - Widespread exposure as an ingredient in natural products - Lack of chronic toxicity data - Test in parallel with linalool INPUT FROM GOVERNMENT AGENCIES/INDUSTRY Dr. Dan Benz, Center for Food Safety and Applied Nutrition (CFSAN), Food and Drug Administration (FDA) and Dr. Ed Matthews (formerly with CFSAN) provided information on citronellol from FDA’s Priority-Based Assessment of Food Additives (PAFA) database. -
Dysprosium-Doped Zinc Tungstate Nanospheres As Highly Efficient Heterogeneous Catalysts in Green Oxidation of Terpenic Alcohols with Hydrogen Peroxide
Electronic Supplementary Material (ESI) for New Journal of Chemistry. This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2021 Dysprosium-doped zinc tungstate nanospheres as highly efficient heterogeneous catalysts in green oxidation of terpenic alcohols with hydrogen peroxide Daniel Carreira Batalha,a Kellen Cristina Mesquita Borges,b Rosana de Fátima Gonçalves,b Murillo Henrique de Matos Rodrigues,b Mário Júnior Godinho,b Humberto Vieira Fajardoc and Márcio José da Silva*a a. Chemistry Department, Federal University of Viçosa, Viçosa, Minas Gerais, CEP 36570‑900, Brazil. b. Chemistry Institute, Federal University of Catalão, Catalão, Goiás, CEP 75.704-020, Brazil. c. Chemistry Department, Federal University of Ouro Preto, Ouro Preto, CEP 35400-000, Minas Gerais, Brazil. SUPPLEMENTAL MATERIAL Neraldehyde epoxide Nerol epoxide Neraldehyde Others Conversion K8SiW11O39 [1] Na2WO4 [2] ZnWO4 - 2.0% Dy This study s Na PW O [3] t 7 11 39 s y l a t a Cs8SiW11O39 [4] C Nb2O5 [5] WO3 - SiO2 - 700 [6] Nb2O5 - SiO2 (a) [7] 0 20 40 60 80 100 Nerol conversion an d selectivities / % Ref.1 - Nerol:H2O2 (1:3); Catalyst (1.3 mol %); solvent DMA; 3 h; 363 K Ref. 2 - Nerol:H2O2 (1:2); Catalyst (1.3 mol %); solvent DMA; 4 h; 363 K This study - Nerol:H2O2 (1:2); Catalyst (3.5 mol %); solvent ACN; 8 h; 333 K Ref. 3 - Nerol:H2O2 (1:1); Catalyst (0.3 mol %); solvent ACN; 4 h; 298 K Ref. 4 - Nerol:H2O2 (1:2); Catalyst (4.0 mol %); solvent ACN; 8 h; 333 K Ref. -
Geraniol Profile Integrated Pest Management Cornell Cooperative Extension Program
http://hdl.handle.net/1813/56127 New York State Geraniol Profile Integrated Pest Management Cornell Cooperative Extension Program Geraniol Profile Active Ingredient Eligible for Minimum Risk Pesticide Use Brian P. Baker and Jennifer A. Grant New York State Integrated Pest Management, Cornell University, Geneva NY Active Ingredient Name: Geraniol Other Names: ß-Geraniol; Lemonol; Geranyl alcohol; trans-Geraniol; Geranial; (E)-Geraniol; Active Components: Geraniol trans-3,7-Dimethyl-2,6-octadien-1-ol; (E)-Nerol; nerol; Geraniol Extra; Vernol CAS Registry #: 106-24-1 Other Codes: BRN: 1722455 & 1722456; U.S. EPA PC Code: 597501 ChemSpider: 13849989; FEMA—2507; RTECS— RG5830000; EC—233-377-1; EINECS : 203-339-4, CA DPR Chem Code: 309 203-377-1; 203-378-7 Summary: Geraniol, a naturally-occurring terpenoid found in food plants, is often used as a fragrance or ingredient in cosmetics. When used as a pesticide, it is primarily a mosquito and tick repellent, or used against mites. Most studies show geraniol poses little risk to the environment or human health, although a portion of the population suffers from sub-lethal allergies upon dermal or inhalation exposure. Pesticidal Uses: As a pesticide, geraniol is used as a mosquito and tick repellent and as an insecticide for other target pests (including mites). It has antimicrobial and fungicidal applications as well. Formulations and Combinations: Often formulated with other essential oils, including citronellol, farne- sol, nerolidol, eugenol, thymol, lemongrass oil, cinnamon oil and cedarwood oil. May be formulated with sodium lauryl sulfate, glycerin, isopropyl myristate, ethyl lactate, cinnemaldehyde, 2-phenylethyl propio- nate, potassium sorbate and mineral oil. -
Compositions for Treating Itch Zusammensetzungen Zur Behandlung Von Juckreiz Compositions Pour Traiter Les Démangeaisons
(19) TZZ Z¥_T (11) EP 2 446 903 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/085 (2006.01) A61K 31/165 (2006.01) 09.10.2019 Bulletin 2019/41 A61K 31/167 (2006.01) A61K 31/14 (2006.01) A61K 9/00 (2006.01) A61K 45/06 (2006.01) (2006.01) (2006.01) (21) Application number: 11007949.8 A61P 17/04 A61P 29/00 (22) Date of filing: 19.11.2007 (54) Compositions for treating itch Zusammensetzungen zur Behandlung von Juckreiz Compositions pour traiter les démangeaisons (84) Designated Contracting States: WO-A2-99/11252 US-A- 3 519 631 AT BE BG CH CY CZ DE DK EE ES FI FR GB GR US-A- 4 069 309 US-B1- 6 362 197 HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE US-B1- 6 413 961 SI SK TR • OMANA-ZAPATA I ET AL: "QX-314 inhibits (30) Priority: 20.11.2006 US 860124 P ectopic nerve activity associated with 06.07.2007 US 958594 P neuropathic pain.", BRAIN RESEARCH 17 OCT 03.10.2007 US 997510 P 1997,vol. 771, no. 2, 17 October 1997 (1997-10-17), pages 228-237, XP002486707, ISSN: 0006-8993 (43) Date of publication of application: • STRICHARTZ G R: "The inhibition of sodium 02.05.2012 Bulletin 2012/18 currents in myelinated nerve by quaternary derivatives of lidocaine.", THE JOURNAL OF (62) Document number(s) of the earlier application(s) in GENERAL PHYSIOLOGY JUL 1973, vol.